May 18, 2017
Mylan NV and Pfizer Inc. on Wednesday each urged the Judicial Panel on Multidistrict Litigation not to consolidate antitrust litigation against the drugmakers, arguing the majority of cases are already working together in Kansas to make the litigation work, so the move is unnecessary.
May 15, 2017
Sanofi-Aventis U.S. LLC urged the Judicial Panel on Multidistrict Litigation on Friday to deny a request to join its suit against Mylan Inc. over an alleged monopoly of EpiPen sales with others, saying its Sherman Act suit brings up different legal issues than putative class actions from direct and indirect purchasers of the pens.